FF:10010-101C1: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=C | |sample_ethnicity=C | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;6.8401102206638e-237!GO:0005737;cytoplasm;4.06315273661994e-172!GO:0043226;organelle;4.48297154597385e-123!GO:0043229;intracellular organelle;1.14085969650104e-122!GO:0043227;membrane-bound organelle;1.6612691791989e-115!GO:0043231;intracellular membrane-bound organelle;2.27938669592026e-115!GO:0044444;cytoplasmic part;2.22863565048866e-112!GO:0005515;protein binding;3.60316115029015e-99!GO:0044422;organelle part;3.73942752350361e-74!GO:0044446;intracellular organelle part;6.09472954057616e-73!GO:0032991;macromolecular complex;2.64731563909915e-61!GO:0044238;primary metabolic process;1.0785941933058e-53!GO:0044237;cellular metabolic process;4.55179796007964e-52!GO:0043170;macromolecule metabolic process;7.26513644020813e-49!GO:0003723;RNA binding;1.58497125603936e-43!GO:0030529;ribonucleoprotein complex;1.69251402502429e-42!GO:0016043;cellular component organization and biogenesis;8.98805348541606e-42!GO:0043233;organelle lumen;1.66345716530713e-41!GO:0031974;membrane-enclosed lumen;1.66345716530713e-41!GO:0044428;nuclear part;1.25617379367646e-38!GO:0005739;mitochondrion;1.90806111032637e-38!GO:0019538;protein metabolic process;5.88763634882985e-38!GO:0005634;nucleus;3.37951985770136e-37!GO:0031090;organelle membrane;5.907322622483e-35!GO:0043234;protein complex;1.67184274264755e-34!GO:0033036;macromolecule localization;1.90434996293211e-34!GO:0015031;protein transport;4.06687180803614e-33!GO:0044260;cellular macromolecule metabolic process;5.28288213647811e-33!GO:0045184;establishment of protein localization;2.17690166179331e-32!GO:0008104;protein localization;6.12040345380547e-32!GO:0005829;cytosol;1.66506114790445e-31!GO:0044267;cellular protein metabolic process;5.95667454053218e-31!GO:0044429;mitochondrial part;2.91980030882161e-28!GO:0006412;translation;7.53220370066831e-28!GO:0031967;organelle envelope;1.13332287239379e-27!GO:0031975;envelope;1.87122969840908e-27!GO:0046907;intracellular transport;2.93742580239537e-27!GO:0005840;ribosome;2.38249174105943e-24!GO:0031981;nuclear lumen;5.15869942544683e-24!GO:0006886;intracellular protein transport;7.72215341231822e-24!GO:0006396;RNA processing;8.93835172854352e-24!GO:0065003;macromolecular complex assembly;1.0354528766745e-23!GO:0016071;mRNA metabolic process;1.29638678177604e-23!GO:0043283;biopolymer metabolic process;1.01753553925153e-22!GO:0022607;cellular component assembly;1.17998413302771e-22!GO:0008380;RNA splicing;1.6044771956025e-22!GO:0009058;biosynthetic process;1.88742932986913e-22!GO:0009059;macromolecule biosynthetic process;3.06853986364884e-22!GO:0044249;cellular biosynthetic process;4.49229144794226e-22!GO:0010467;gene expression;1.00354891136782e-20!GO:0003735;structural constituent of ribosome;1.18608566169571e-20!GO:0006397;mRNA processing;1.48385052347232e-19!GO:0005740;mitochondrial envelope;1.78100777664968e-19!GO:0031966;mitochondrial membrane;3.28767790430889e-19!GO:0033279;ribosomal subunit;6.26564393920914e-19!GO:0000166;nucleotide binding;8.0821548483098e-19!GO:0008092;cytoskeletal protein binding;1.42770843523066e-18!GO:0051641;cellular localization;3.32579770087774e-18!GO:0051649;establishment of cellular localization;3.32579770087774e-18!GO:0008134;transcription factor binding;5.71499026077969e-18!GO:0048770;pigment granule;9.71077933861657e-18!GO:0042470;melanosome;9.71077933861657e-18!GO:0006996;organelle organization and biogenesis;1.19094058503063e-17!GO:0016192;vesicle-mediated transport;4.73940641427803e-17!GO:0019866;organelle inner membrane;7.01996761765581e-17!GO:0022613;ribonucleoprotein complex biogenesis and assembly;2.76331399278772e-16!GO:0043228;non-membrane-bound organelle;3.68939361021918e-16!GO:0043232;intracellular non-membrane-bound organelle;3.68939361021918e-16!GO:0005783;endoplasmic reticulum;6.55202964834286e-16!GO:0005830;cytosolic ribosome (sensu Eukaryota);9.73226389351043e-16!GO:0005743;mitochondrial inner membrane;9.86593565861432e-16!GO:0005654;nucleoplasm;2.37102630908261e-15!GO:0005681;spliceosome;3.48838523702515e-15!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;4.52076577949959e-15!GO:0006119;oxidative phosphorylation;4.52076577949959e-15!GO:0044445;cytosolic part;7.99404258118847e-15!GO:0044265;cellular macromolecule catabolic process;2.17484490047792e-14!GO:0030036;actin cytoskeleton organization and biogenesis;3.81243015556012e-14!GO:0017076;purine nucleotide binding;6.58570250780416e-14!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;1.08196381470813e-13!GO:0016462;pyrophosphatase activity;1.10560209267375e-13!GO:0016817;hydrolase activity, acting on acid anhydrides;1.46995183998062e-13!GO:0012505;endomembrane system;1.71213550070011e-13!GO:0044451;nucleoplasm part;2.33335121819535e-13!GO:0017111;nucleoside-triphosphatase activity;2.41543801473337e-13!GO:0032553;ribonucleotide binding;2.76828880422112e-13!GO:0032555;purine ribonucleotide binding;2.76828880422112e-13!GO:0051603;proteolysis involved in cellular protein catabolic process;3.17398786028169e-13!GO:0012501;programmed cell death;4.01118654473872e-13!GO:0030029;actin filament-based process;4.2470568171802e-13!GO:0006915;apoptosis;5.89317904112381e-13!GO:0048523;negative regulation of cellular process;6.07792195173139e-13!GO:0022618;protein-RNA complex assembly;6.13695599063377e-13!GO:0019941;modification-dependent protein catabolic process;6.35276787496473e-13!GO:0043632;modification-dependent macromolecule catabolic process;6.35276787496473e-13!GO:0044257;cellular protein catabolic process;8.71269222798249e-13!GO:0008219;cell death;8.83108718698364e-13!GO:0016265;death;8.83108718698364e-13!GO:0016874;ligase activity;8.83108718698364e-13!GO:0006511;ubiquitin-dependent protein catabolic process;9.12405173833269e-13!GO:0003779;actin binding;1.25166726224416e-12!GO:0043285;biopolymer catabolic process;1.40817197368358e-12!GO:0006512;ubiquitin cycle;1.60814222990957e-12!GO:0044248;cellular catabolic process;1.83787194675081e-12!GO:0050789;regulation of biological process;3.10164681690557e-12!GO:0006461;protein complex assembly;4.20347427051004e-12!GO:0005794;Golgi apparatus;4.94797399110652e-12!GO:0050794;regulation of cellular process;7.67223244095068e-12!GO:0031980;mitochondrial lumen;8.05689471536141e-12!GO:0005759;mitochondrial matrix;8.05689471536141e-12!GO:0006605;protein targeting;8.53061802848178e-12!GO:0009057;macromolecule catabolic process;1.11190051097913e-11!GO:0048519;negative regulation of biological process;1.1331978868351e-11!GO:0048193;Golgi vesicle transport;3.99904479397476e-11!GO:0008135;translation factor activity, nucleic acid binding;4.03002888863754e-11!GO:0005773;vacuole;4.0482245041634e-11!GO:0015935;small ribosomal subunit;4.08241934851249e-11!GO:0051186;cofactor metabolic process;4.6049630618761e-11!GO:0030163;protein catabolic process;5.05830966204146e-11!GO:0006457;protein folding;5.13689421212585e-11!GO:0003712;transcription cofactor activity;5.92203173437883e-11!GO:0015629;actin cytoskeleton;6.55149162308135e-11!GO:0044432;endoplasmic reticulum part;9.08429071571939e-11!GO:0000502;proteasome complex (sensu Eukaryota);1.04235514876053e-10!GO:0000323;lytic vacuole;1.46688859983137e-10!GO:0005764;lysosome;1.46688859983137e-10!GO:0043412;biopolymer modification;1.51110875158306e-10!GO:0005746;mitochondrial respiratory chain;1.7562103804758e-10!GO:0044455;mitochondrial membrane part;2.23141011729812e-10!GO:0043687;post-translational protein modification;2.28975215115293e-10!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;3.53802605691158e-10!GO:0006464;protein modification process;6.79522440252983e-10!GO:0005768;endosome;8.37837408923338e-10!GO:0006366;transcription from RNA polymerase II promoter;8.55413846932276e-10!GO:0031252;leading edge;8.63518695619635e-10!GO:0006913;nucleocytoplasmic transport;1.60649200789646e-09!GO:0005730;nucleolus;2.21276825976804e-09!GO:0050136;NADH dehydrogenase (quinone) activity;2.21851742327891e-09!GO:0003954;NADH dehydrogenase activity;2.21851742327891e-09!GO:0008137;NADH dehydrogenase (ubiquinone) activity;2.21851742327891e-09!GO:0008565;protein transporter activity;2.55031588855761e-09!GO:0030554;adenyl nucleotide binding;2.6048208848385e-09!GO:0005635;nuclear envelope;3.36439918933158e-09!GO:0016604;nuclear body;3.53660398051641e-09!GO:0065007;biological regulation;3.79431280045975e-09!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.8631562669909e-09!GO:0003743;translation initiation factor activity;3.98649481755351e-09!GO:0051169;nuclear transport;4.26912682285406e-09!GO:0031982;vesicle;4.40183615989619e-09!GO:0006446;regulation of translational initiation;4.4181785222227e-09!GO:0032559;adenyl ribonucleotide binding;8.09191004235865e-09!GO:0015934;large ribosomal subunit;8.40543695702156e-09!GO:0051246;regulation of protein metabolic process;9.10456836493755e-09!GO:0031988;membrane-bound vesicle;1.02901717936686e-08!GO:0006732;coenzyme metabolic process;1.13173409807681e-08!GO:0016070;RNA metabolic process;1.15076958495757e-08!GO:0019899;enzyme binding;1.15507668349185e-08!GO:0005524;ATP binding;1.22814214593996e-08!GO:0031410;cytoplasmic vesicle;1.41732110796152e-08!GO:0015980;energy derivation by oxidation of organic compounds;1.44412427399701e-08!GO:0051082;unfolded protein binding;1.44412427399701e-08!GO:0006413;translational initiation;1.58161463180347e-08!GO:0005793;ER-Golgi intermediate compartment;2.06917489246617e-08!GO:0016044;membrane organization and biogenesis;2.1223379033815e-08!GO:0016023;cytoplasmic membrane-bound vesicle;2.67974208210846e-08!GO:0007243;protein kinase cascade;2.98279467784167e-08!GO:0006793;phosphorus metabolic process;3.11646703068613e-08!GO:0006796;phosphate metabolic process;3.11646703068613e-08!GO:0042981;regulation of apoptosis;3.23739488920252e-08!GO:0016564;transcription repressor activity;3.38620446183816e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;3.47349696888032e-08!GO:0006950;response to stress;3.60805704776793e-08!GO:0009056;catabolic process;3.85019356741022e-08!GO:0043067;regulation of programmed cell death;5.12096237891496e-08!GO:0003676;nucleic acid binding;5.6064860949756e-08!GO:0000398;nuclear mRNA splicing, via spliceosome;5.72917432457498e-08!GO:0000375;RNA splicing, via transesterification reactions;5.72917432457498e-08!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;5.72917432457498e-08!GO:0030964;NADH dehydrogenase complex (quinone);6.80576466447445e-08!GO:0045271;respiratory chain complex I;6.80576466447445e-08!GO:0005747;mitochondrial respiratory chain complex I;6.80576466447445e-08!GO:0042775;organelle ATP synthesis coupled electron transport;7.83640041195419e-08!GO:0042773;ATP synthesis coupled electron transport;7.83640041195419e-08!GO:0016607;nuclear speck;7.91214406544477e-08!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;8.18975691272932e-08!GO:0009055;electron carrier activity;8.48290982411564e-08!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;8.68162291173594e-08!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;1.18441321110576e-07!GO:0008639;small protein conjugating enzyme activity;1.24904760916767e-07!GO:0007264;small GTPase mediated signal transduction;1.25975250381788e-07!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;1.86514754350235e-07!GO:0045333;cellular respiration;1.91940726849055e-07!GO:0004842;ubiquitin-protein ligase activity;2.04804551136515e-07!GO:0043069;negative regulation of programmed cell death;2.13238986700031e-07!GO:0031965;nuclear membrane;2.18264988375455e-07!GO:0017038;protein import;2.18264988375455e-07!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;2.23462900763714e-07!GO:0009060;aerobic respiration;2.28013221853328e-07!GO:0003924;GTPase activity;2.35492732337326e-07!GO:0005525;GTP binding;2.42690999455396e-07!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);2.62768510740991e-07!GO:0043066;negative regulation of apoptosis;2.80198660085349e-07!GO:0042175;nuclear envelope-endoplasmic reticulum network;3.42780337283057e-07!GO:0006091;generation of precursor metabolites and energy;3.49810867269575e-07!GO:0005789;endoplasmic reticulum membrane;3.63298018672123e-07!GO:0019829;cation-transporting ATPase activity;3.96957006039759e-07!GO:0019787;small conjugating protein ligase activity;4.67637266553006e-07!GO:0016310;phosphorylation;4.72636429508009e-07!GO:0048522;positive regulation of cellular process;4.96406972207982e-07!GO:0007249;I-kappaB kinase/NF-kappaB cascade;7.59369462801654e-07!GO:0007010;cytoskeleton organization and biogenesis;7.76679462645702e-07!GO:0007242;intracellular signaling cascade;1.01157647082044e-06!GO:0015986;ATP synthesis coupled proton transport;1.01157647082044e-06!GO:0015985;energy coupled proton transport, down electrochemical gradient;1.01157647082044e-06!GO:0016469;proton-transporting two-sector ATPase complex;1.10142298497045e-06!GO:0003714;transcription corepressor activity;1.1347913396762e-06!GO:0005770;late endosome;1.33087976970254e-06!GO:0016887;ATPase activity;1.3667827879505e-06!GO:0048475;coated membrane;1.58157317458141e-06!GO:0030117;membrane coat;1.58157317458141e-06!GO:0009892;negative regulation of metabolic process;1.61995104035721e-06!GO:0009150;purine ribonucleotide metabolic process;1.98237703629414e-06!GO:0032561;guanyl ribonucleotide binding;2.03450758005336e-06!GO:0019001;guanyl nucleotide binding;2.03450758005336e-06!GO:0006099;tricarboxylic acid cycle;2.13679903691145e-06!GO:0046356;acetyl-CoA catabolic process;2.13679903691145e-06!GO:0006916;anti-apoptosis;2.25354602832841e-06!GO:0051187;cofactor catabolic process;2.26179391645832e-06!GO:0005761;mitochondrial ribosome;2.26179391645832e-06!GO:0000313;organellar ribosome;2.26179391645832e-06!GO:0006163;purine nucleotide metabolic process;2.28750438356778e-06!GO:0048518;positive regulation of biological process;2.54708818479281e-06!GO:0007265;Ras protein signal transduction;2.73251026441613e-06!GO:0031324;negative regulation of cellular metabolic process;2.88488077201665e-06!GO:0009109;coenzyme catabolic process;2.93388099598818e-06!GO:0015078;hydrogen ion transmembrane transporter activity;2.97643318535229e-06!GO:0009966;regulation of signal transduction;3.18655684760605e-06!GO:0009259;ribonucleotide metabolic process;3.21593127764414e-06!GO:0008361;regulation of cell size;3.37798709990683e-06!GO:0051170;nuclear import;3.76311596518675e-06!GO:0006606;protein import into nucleus;3.81289267763454e-06!GO:0044440;endosomal part;3.96048656893279e-06!GO:0010008;endosome membrane;3.96048656893279e-06!GO:0006259;DNA metabolic process;4.57434239112264e-06!GO:0016879;ligase activity, forming carbon-nitrogen bonds;4.6866274314582e-06!GO:0046034;ATP metabolic process;4.76772071864501e-06!GO:0003713;transcription coactivator activity;4.9177880915138e-06!GO:0016049;cell growth;5.10362482245915e-06!GO:0006897;endocytosis;5.65558900531179e-06!GO:0010324;membrane invagination;5.65558900531179e-06!GO:0006084;acetyl-CoA metabolic process;6.45720531136766e-06!GO:0042623;ATPase activity, coupled;7.57931949976486e-06!GO:0009205;purine ribonucleoside triphosphate metabolic process;7.95972643140046e-06!GO:0009144;purine nucleoside triphosphate metabolic process;7.95972643140046e-06!GO:0001726;ruffle;9.12325099081324e-06!GO:0030120;vesicle coat;9.27736190990489e-06!GO:0030662;coated vesicle membrane;9.27736190990489e-06!GO:0009199;ribonucleoside triphosphate metabolic process;9.62330355825668e-06!GO:0005788;endoplasmic reticulum lumen;1.09610591790105e-05!GO:0009141;nucleoside triphosphate metabolic process;1.1323644861501e-05!GO:0006888;ER to Golgi vesicle-mediated transport;1.30647947888752e-05!GO:0044453;nuclear membrane part;1.31633383558728e-05!GO:0030695;GTPase regulator activity;1.33768654509345e-05!GO:0005083;small GTPase regulator activity;1.45409892725167e-05!GO:0006357;regulation of transcription from RNA polymerase II promoter;1.6098272274942e-05!GO:0016881;acid-amino acid ligase activity;1.80978029020257e-05!GO:0016197;endosome transport;1.92705983138496e-05!GO:0044262;cellular carbohydrate metabolic process;2.53819471001674e-05!GO:0016563;transcription activator activity;2.54509541671171e-05!GO:0005741;mitochondrial outer membrane;2.57699666715011e-05!GO:0001558;regulation of cell growth;2.60774364388575e-05!GO:0009152;purine ribonucleotide biosynthetic process;2.89353973595353e-05!GO:0006754;ATP biosynthetic process;3.15623428202851e-05!GO:0006753;nucleoside phosphate metabolic process;3.15623428202851e-05!GO:0006164;purine nucleotide biosynthetic process;3.19239702815934e-05!GO:0051128;regulation of cellular component organization and biogenesis;3.40178988513759e-05!GO:0016481;negative regulation of transcription;3.57510059466262e-05!GO:0005839;proteasome core complex (sensu Eukaryota);4.10738304899488e-05!GO:0030027;lamellipodium;4.34005889531252e-05!GO:0031968;organelle outer membrane;4.88503294061142e-05!GO:0016491;oxidoreductase activity;5.25361677912784e-05!GO:0019867;outer membrane;5.53885692576882e-05!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;5.75982313329051e-05!GO:0009145;purine nucleoside triphosphate biosynthetic process;5.75982313329051e-05!GO:0009260;ribonucleotide biosynthetic process;6.69950741384172e-05!GO:0042802;identical protein binding;6.74067776817759e-05!GO:0009142;nucleoside triphosphate biosynthetic process;6.9860385788345e-05!GO:0009201;ribonucleoside triphosphate biosynthetic process;6.9860385788345e-05!GO:0030133;transport vesicle;7.54801972781643e-05!GO:0006613;cotranslational protein targeting to membrane;7.76838670199503e-05!GO:0005798;Golgi-associated vesicle;9.11376491024206e-05!GO:0043566;structure-specific DNA binding;9.52710228466627e-05!GO:0004386;helicase activity;9.6408531456358e-05!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;9.77557332664083e-05!GO:0050657;nucleic acid transport;9.84281349558478e-05!GO:0051236;establishment of RNA localization;9.84281349558478e-05!GO:0050658;RNA transport;9.84281349558478e-05!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;9.8738065509718e-05!GO:0042254;ribosome biogenesis and assembly;9.91831662981584e-05!GO:0005643;nuclear pore;0.000105942607155574!GO:0008047;enzyme activator activity;0.000109409806642753!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000110204255487489!GO:0006403;RNA localization;0.000115245301987569!GO:0045786;negative regulation of progression through cell cycle;0.000115624437977454!GO:0001666;response to hypoxia;0.000122496564847919!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.00013196973465609!GO:0008654;phospholipid biosynthetic process;0.000132429708937433!GO:0008026;ATP-dependent helicase activity;0.000145878536261099!GO:0007266;Rho protein signal transduction;0.000147990095156156!GO:0005096;GTPase activator activity;0.000150720732244667!GO:0005791;rough endoplasmic reticulum;0.000183426800851908!GO:0004298;threonine endopeptidase activity;0.00021407111563407!GO:0008154;actin polymerization and/or depolymerization;0.000221235004195315!GO:0009967;positive regulation of signal transduction;0.000242856642179246!GO:0051188;cofactor biosynthetic process;0.000249790063021081!GO:0065009;regulation of a molecular function;0.000259217129214012!GO:0045259;proton-transporting ATP synthase complex;0.00026403495530319!GO:0051789;response to protein stimulus;0.000279488168584781!GO:0006986;response to unfolded protein;0.000279488168584781!GO:0000245;spliceosome assembly;0.000283659310272293!GO:0044431;Golgi apparatus part;0.000284668350664735!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.000286100697919693!GO:0003697;single-stranded DNA binding;0.000286100697919693!GO:0051427;hormone receptor binding;0.000297138330331036!GO:0003724;RNA helicase activity;0.000330397563855462!GO:0030867;rough endoplasmic reticulum membrane;0.000345740203897101!GO:0008286;insulin receptor signaling pathway;0.000362648527583507!GO:0048471;perinuclear region of cytoplasm;0.000395843837756994!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.000396795435835834!GO:0046930;pore complex;0.000430003884408651!GO:0032446;protein modification by small protein conjugation;0.000430534503218471!GO:0005048;signal sequence binding;0.000436801801298044!GO:0005100;Rho GTPase activator activity;0.000449799568842595!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.000452142774630917!GO:0004812;aminoacyl-tRNA ligase activity;0.000452142774630917!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.000452142774630917!GO:0009615;response to virus;0.00046147493930364!GO:0030041;actin filament polymerization;0.0004705464776122!GO:0005769;early endosome;0.000504676520891268!GO:0040008;regulation of growth;0.000544631937307327!GO:0035257;nuclear hormone receptor binding;0.000544631937307327!GO:0016567;protein ubiquitination;0.000563236933088784!GO:0009117;nucleotide metabolic process;0.000577150110348674!GO:0007049;cell cycle;0.000630416524580215!GO:0046983;protein dimerization activity;0.000721193176784222!GO:0005774;vacuolar membrane;0.000777840155846148!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.000793907941757584!GO:0019222;regulation of metabolic process;0.000819044829280409!GO:0048468;cell development;0.000820353885415125!GO:0000151;ubiquitin ligase complex;0.000837867475846572!GO:0043038;amino acid activation;0.000863029229848931!GO:0006418;tRNA aminoacylation for protein translation;0.000863029229848931!GO:0043039;tRNA aminoacylation;0.000863029229848931!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.000863029229848931!GO:0005905;coated pit;0.000863029229848931!GO:0009108;coenzyme biosynthetic process;0.000865404565078117!GO:0031902;late endosome membrane;0.000884860544841639!GO:0005667;transcription factor complex;0.000889824348655804!GO:0065002;intracellular protein transport across a membrane;0.000893104741309676!GO:0006752;group transfer coenzyme metabolic process;0.000904714809552012!GO:0005885;Arp2/3 protein complex;0.000975487913010246!GO:0051287;NAD binding;0.000985882673800898!GO:0001725;stress fiber;0.00100716197384991!GO:0032432;actin filament bundle;0.00100716197384991!GO:0045892;negative regulation of transcription, DNA-dependent;0.00103149088847054!GO:0030532;small nuclear ribonucleoprotein complex;0.00121400072431226!GO:0051028;mRNA transport;0.00128169160383156!GO:0019752;carboxylic acid metabolic process;0.00133283409513589!GO:0005765;lysosomal membrane;0.00143227593373885!GO:0033673;negative regulation of kinase activity;0.00145208503294656!GO:0006469;negative regulation of protein kinase activity;0.00145208503294656!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00149181021637956!GO:0006607;NLS-bearing substrate import into nucleus;0.00156700153832294!GO:0051726;regulation of cell cycle;0.00159462603621321!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00160691234579843!GO:0006082;organic acid metabolic process;0.00164787211464923!GO:0000074;regulation of progression through cell cycle;0.00165830781789281!GO:0006006;glucose metabolic process;0.00166066563141885!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.00179751684407765!GO:0050662;coenzyme binding;0.0018041932861492!GO:0016787;hydrolase activity;0.00181936299749603!GO:0005099;Ras GTPase activator activity;0.00189488890605525!GO:0007179;transforming growth factor beta receptor signaling pathway;0.00201196596020042!GO:0006612;protein targeting to membrane;0.00210494185461293!GO:0006974;response to DNA damage stimulus;0.00224529073207714!GO:0030518;steroid hormone receptor signaling pathway;0.00224529073207714!GO:0032787;monocarboxylic acid metabolic process;0.00224529073207714!GO:0043021;ribonucleoprotein binding;0.00228038123466124!GO:0031589;cell-substrate adhesion;0.00232329610216326!GO:0035258;steroid hormone receptor binding;0.00238949201199188!GO:0001568;blood vessel development;0.00264240008963535!GO:0001944;vasculature development;0.00270965061102113!GO:0030118;clathrin coat;0.00280269800039115!GO:0019843;rRNA binding;0.00280946221638891!GO:0051348;negative regulation of transferase activity;0.00289835567083361!GO:0008186;RNA-dependent ATPase activity;0.00299819936587596!GO:0007005;mitochondrion organization and biogenesis;0.00320754489527916!GO:0008250;oligosaccharyl transferase complex;0.00328569746374013!GO:0044437;vacuolar part;0.00331722177998901!GO:0006693;prostaglandin metabolic process;0.00331722177998901!GO:0006692;prostanoid metabolic process;0.00331722177998901!GO:0022890;inorganic cation transmembrane transporter activity;0.00337418928051033!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.00346949865448961!GO:0033043;regulation of organelle organization and biogenesis;0.00346949865448961!GO:0006979;response to oxidative stress;0.00357204358858149!GO:0051920;peroxiredoxin activity;0.00399122423304538!GO:0044449;contractile fiber part;0.00400578831298233!GO:0009719;response to endogenous stimulus;0.0040491975834419!GO:0030031;cell projection biogenesis;0.00431147668810733!GO:0008307;structural constituent of muscle;0.00448500215934284!GO:0019318;hexose metabolic process;0.00448500215934284!GO:0006325;establishment and/or maintenance of chromatin architecture;0.0045871281614357!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.00459801498622602!GO:0015399;primary active transmembrane transporter activity;0.00459801498622602!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.00468930048112815!GO:0007160;cell-matrix adhesion;0.00486700018967045!GO:0007034;vacuolar transport;0.00487368361104811!GO:0003690;double-stranded DNA binding;0.00506068312234415!GO:0007517;muscle development;0.00510816424563929!GO:0006417;regulation of translation;0.00512039568647085!GO:0006635;fatty acid beta-oxidation;0.00523876545465226!GO:0006402;mRNA catabolic process;0.00553815554647836!GO:0006364;rRNA processing;0.00563225069418814!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00569915417024786!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00569915417024786!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00569915417024786!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;0.00589487809396303!GO:0017166;vinculin binding;0.0059607184747873!GO:0043292;contractile fiber;0.00603730561136108!GO:0045893;positive regulation of transcription, DNA-dependent;0.00604628379605095!GO:0007041;lysosomal transport;0.00624385202247417!GO:0030865;cortical cytoskeleton organization and biogenesis;0.00624385202247417!GO:0000139;Golgi membrane;0.00627629343921624!GO:0050790;regulation of catalytic activity;0.00627828926339775!GO:0033116;ER-Golgi intermediate compartment membrane;0.00652613736729154!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00666752570560753!GO:0005912;adherens junction;0.00666800152257825!GO:0030521;androgen receptor signaling pathway;0.0067314399429271!GO:0043623;cellular protein complex assembly;0.0067314399429271!GO:0007050;cell cycle arrest;0.00679371178759239!GO:0016568;chromatin modification;0.00688859728993585!GO:0008139;nuclear localization sequence binding;0.00700872046951713!GO:0005996;monosaccharide metabolic process;0.00716912483561359!GO:0030016;myofibril;0.00723341955727225!GO:0045941;positive regulation of transcription;0.00734428163777303!GO:0051087;chaperone binding;0.00742104002541221!GO:0043065;positive regulation of apoptosis;0.00747629939966393!GO:0016281;eukaryotic translation initiation factor 4F complex;0.00747805803267012!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00752806223273222!GO:0006891;intra-Golgi vesicle-mediated transport;0.00754139371579053!GO:0004004;ATP-dependent RNA helicase activity;0.00764488355035514!GO:0004576;oligosaccharyl transferase activity;0.00791639337137242!GO:0030522;intracellular receptor-mediated signaling pathway;0.00796840495617021!GO:0043492;ATPase activity, coupled to movement of substances;0.0081085566182592!GO:0009889;regulation of biosynthetic process;0.00820397872318324!GO:0031326;regulation of cellular biosynthetic process;0.00825012358645742!GO:0006323;DNA packaging;0.00843526026134626!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00894192140841901!GO:0016072;rRNA metabolic process;0.00913462146215015!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00917053374285538!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.00917053374285538!GO:0030663;COPI coated vesicle membrane;0.00923096135022511!GO:0030126;COPI vesicle coat;0.00923096135022511!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;0.00974601267055896!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.00976443106787328!GO:0045792;negative regulation of cell size;0.00976443106787328!GO:0032956;regulation of actin cytoskeleton organization and biogenesis;0.0098409182744574!GO:0043488;regulation of mRNA stability;0.00995082369573766!GO:0043487;regulation of RNA stability;0.00995082369573766!GO:0032535;regulation of cellular component size;0.0100754600927273!GO:0004177;aminopeptidase activity;0.0101218555983422!GO:0051168;nuclear export;0.0101218555983422!GO:0030832;regulation of actin filament length;0.0102206255863507!GO:0030055;cell-matrix junction;0.0103551617936534!GO:0043068;positive regulation of programmed cell death;0.0105866852267086!GO:0017022;myosin binding;0.010615774443529!GO:0004860;protein kinase inhibitor activity;0.0109783838060241!GO:0045637;regulation of myeloid cell differentiation;0.0109902313926899!GO:0007040;lysosome organization and biogenesis;0.0114106689376059!GO:0030132;clathrin coat of coated pit;0.0116727885401413!GO:0030100;regulation of endocytosis;0.0116727885401413!GO:0046467;membrane lipid biosynthetic process;0.0116908254662277!GO:0030308;negative regulation of cell growth;0.0117368658682397!GO:0051270;regulation of cell motility;0.0117866915861763!GO:0005924;cell-substrate adherens junction;0.0120296052727119!GO:0005856;cytoskeleton;0.0120653895683727!GO:0008064;regulation of actin polymerization and/or depolymerization;0.0121322087818449!GO:0051252;regulation of RNA metabolic process;0.0121919276582997!GO:0051540;metal cluster binding;0.0122912634669453!GO:0051536;iron-sulfur cluster binding;0.0122912634669453!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0126588094715673!GO:0050811;GABA receptor binding;0.0127135606441335!GO:0030155;regulation of cell adhesion;0.0129845929244808!GO:0048660;regulation of smooth muscle cell proliferation;0.0130931939462786!GO:0030099;myeloid cell differentiation;0.0131710341493257!GO:0003729;mRNA binding;0.0132488564036039!GO:0016859;cis-trans isomerase activity;0.0132621695181771!GO:0019902;phosphatase binding;0.013491610283964!GO:0016791;phosphoric monoester hydrolase activity;0.0137879048813091!GO:0048500;signal recognition particle;0.0139443346778465!GO:0005865;striated muscle thin filament;0.0140554487402601!GO:0046474;glycerophospholipid biosynthetic process;0.0141058766249101!GO:0045045;secretory pathway;0.0141376059598418!GO:0030134;ER to Golgi transport vesicle;0.01420147428832!GO:0006414;translational elongation;0.0143976923600956!GO:0051098;regulation of binding;0.0143976923600956!GO:0030127;COPII vesicle coat;0.0145223358454074!GO:0012507;ER to Golgi transport vesicle membrane;0.0145223358454074!GO:0016363;nuclear matrix;0.0146231052823226!GO:0006401;RNA catabolic process;0.0152545680830635!GO:0019904;protein domain specific binding;0.0152753759601747!GO:0006892;post-Golgi vesicle-mediated transport;0.0157023120026884!GO:0032940;secretion by cell;0.0157245322988709!GO:0030119;AP-type membrane coat adaptor complex;0.015828453624395!GO:0018196;peptidyl-asparagine modification;0.0160518024341983!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.0160518024341983!GO:0051336;regulation of hydrolase activity;0.0160518024341983!GO:0005862;muscle thin filament tropomyosin;0.0161757353168043!GO:0001525;angiogenesis;0.0164542564649573!GO:0016779;nucleotidyltransferase activity;0.0167075069375936!GO:0007167;enzyme linked receptor protein signaling pathway;0.0169520025058894!GO:0019838;growth factor binding;0.0172815162750682!GO:0048659;smooth muscle cell proliferation;0.0182105449026742!GO:0030137;COPI-coated vesicle;0.0182304919067163!GO:0030866;cortical actin cytoskeleton organization and biogenesis;0.018384298923151!GO:0008287;protein serine/threonine phosphatase complex;0.0185442752651375!GO:0016853;isomerase activity;0.0189304953021423!GO:0015992;proton transport;0.0191253192928633!GO:0030131;clathrin adaptor complex;0.0194779951244403!GO:0035035;histone acetyltransferase binding;0.0196568921465837!GO:0005813;centrosome;0.0197828439225536!GO:0048514;blood vessel morphogenesis;0.0197828439225536!GO:0008283;cell proliferation;0.0197828439225536!GO:0031901;early endosome membrane;0.0199404991954853!GO:0045454;cell redox homeostasis;0.0200179080731987!GO:0008234;cysteine-type peptidase activity;0.0201070929391615!GO:0006818;hydrogen transport;0.0207922077369776!GO:0006399;tRNA metabolic process;0.0210661339365973!GO:0043086;negative regulation of catalytic activity;0.0210704436620694!GO:0007033;vacuole organization and biogenesis;0.0212258641304909!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0213300183970519!GO:0015002;heme-copper terminal oxidase activity;0.0213300183970519!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0213300183970519!GO:0004129;cytochrome-c oxidase activity;0.0213300183970519!GO:0048154;S100 beta binding;0.0215328004015027!GO:0005159;insulin-like growth factor receptor binding;0.0216660010828421!GO:0048487;beta-tubulin binding;0.0217061134283374!GO:0009893;positive regulation of metabolic process;0.0220702378883125!GO:0006631;fatty acid metabolic process;0.0221710434744637!GO:0031032;actomyosin structure organization and biogenesis;0.022348801861839!GO:0051101;regulation of DNA binding;0.022430958793062!GO:0051235;maintenance of localization;0.0228635422364767!GO:0008610;lipid biosynthetic process;0.0230541268901933!GO:0005762;mitochondrial large ribosomal subunit;0.0230541268901933!GO:0000315;organellar large ribosomal subunit;0.0230541268901933!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0231686191328815!GO:0009165;nucleotide biosynthetic process;0.0231686191328815!GO:0022603;regulation of anatomical structure morphogenesis;0.0231686191328815!GO:0008360;regulation of cell shape;0.0231686191328815!GO:0022604;regulation of cell morphogenesis;0.0231686191328815!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0234175714651531!GO:0006650;glycerophospholipid metabolic process;0.0237499882959162!GO:0030658;transport vesicle membrane;0.0239490505922635!GO:0006509;membrane protein ectodomain proteolysis;0.0239613337643769!GO:0033619;membrane protein proteolysis;0.0239613337643769!GO:0045926;negative regulation of growth;0.024150478798464!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0246967961812979!GO:0017091;AU-rich element binding;0.0247311979086143!GO:0050779;RNA destabilization;0.0247311979086143!GO:0000289;poly(A) tail shortening;0.0247311979086143!GO:0051539;4 iron, 4 sulfur cluster binding;0.0249203900580738!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.024970449466643!GO:0045047;protein targeting to ER;0.024970449466643!GO:0030218;erythrocyte differentiation;0.0251914387896073!GO:0008629;induction of apoptosis by intracellular signals;0.0254271169420929!GO:0006376;mRNA splice site selection;0.0254271169420929!GO:0000389;nuclear mRNA 3'-splice site recognition;0.0254271169420929!GO:0043284;biopolymer biosynthetic process;0.0255370434786303!GO:0030984;kininogen binding;0.0258180214563272!GO:0004213;cathepsin B activity;0.0258180214563272!GO:0043087;regulation of GTPase activity;0.0259718237233017!GO:0051049;regulation of transport;0.0265222971882105!GO:0000902;cell morphogenesis;0.026707489168947!GO:0032989;cellular structure morphogenesis;0.026707489168947!GO:0051259;protein oligomerization;0.0269720840853293!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0273529266840908!GO:0044255;cellular lipid metabolic process;0.0274399145254162!GO:0031349;positive regulation of defense response;0.0276253291454058!GO:0050729;positive regulation of inflammatory response;0.0276253291454058!GO:0050681;androgen receptor binding;0.0281028198734966!GO:0045639;positive regulation of myeloid cell differentiation;0.0282672153569576!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0283836720558975!GO:0004185;serine carboxypeptidase activity;0.0286786948428552!GO:0046578;regulation of Ras protein signal transduction;0.028680135655403!GO:0051276;chromosome organization and biogenesis;0.0290206227312461!GO:0003746;translation elongation factor activity;0.0290206227312461!GO:0005869;dynactin complex;0.0290621878618922!GO:0022415;viral reproductive process;0.0290621878618922!GO:0004197;cysteine-type endopeptidase activity;0.0290621878618922!GO:0040011;locomotion;0.0302014589302625!GO:0005975;carbohydrate metabolic process;0.0303531151962467!GO:0051056;regulation of small GTPase mediated signal transduction;0.0306967916290839!GO:0030833;regulation of actin filament polymerization;0.0321196578228664!GO:0005057;receptor signaling protein activity;0.0330486697904574!GO:0022402;cell cycle process;0.0331417047591665!GO:0065004;protein-DNA complex assembly;0.0332386790761929!GO:0032763;regulation of mast cell cytokine production;0.0334830554399955!GO:0032762;mast cell cytokine production;0.0334830554399955!GO:0043407;negative regulation of MAP kinase activity;0.0335878510724022!GO:0008383;manganese superoxide dismutase activity;0.0339125604831171!GO:0001315;age-dependent response to reactive oxygen species;0.0339125604831171!GO:0047485;protein N-terminus binding;0.0339238330924517!GO:0005925;focal adhesion;0.0340206720610758!GO:0006026;aminoglycan catabolic process;0.0342334304419923!GO:0006027;glycosaminoglycan catabolic process;0.0342334304419923!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.0343388615278172!GO:0019210;kinase inhibitor activity;0.0345856283290034!GO:0004721;phosphoprotein phosphatase activity;0.0346690407734746!GO:0008333;endosome to lysosome transport;0.0347427567820183!GO:0051674;localization of cell;0.0356988087808548!GO:0006928;cell motility;0.0356988087808548!GO:0051338;regulation of transferase activity;0.0356988087808548!GO:0003702;RNA polymerase II transcription factor activity;0.0362061382088697!GO:0031625;ubiquitin protein ligase binding;0.0362061382088697!GO:0040012;regulation of locomotion;0.036367082832996!GO:0030017;sarcomere;0.0365079440195527!GO:0008312;7S RNA binding;0.0377317548366566!GO:0007162;negative regulation of cell adhesion;0.0380835309763837!GO:0016584;nucleosome positioning;0.0381751032045005!GO:0019395;fatty acid oxidation;0.0391262988523035!GO:0043549;regulation of kinase activity;0.0391262988523035!GO:0004722;protein serine/threonine phosphatase activity;0.0392090122427687!GO:0042805;actinin binding;0.0392090122427687!GO:0003817;complement factor D activity;0.0393443795926186!GO:0007015;actin filament organization;0.0396394070522259!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0398869038444461!GO:0016740;transferase activity;0.0398869038444461!GO:0008147;structural constituent of bone;0.0398869038444461!GO:0005062;hematopoietin/interferon-class (D200-domain) cytokine receptor signal transducer activity;0.0403026466821009!GO:0000059;protein import into nucleus, docking;0.0404983663477113!GO:0006281;DNA repair;0.0405780759525058!GO:0004563;beta-N-acetylhexosaminidase activity;0.0412113540730763!GO:0004300;enoyl-CoA hydratase activity;0.0414868376864118!GO:0012506;vesicle membrane;0.0420621027739932!GO:0000314;organellar small ribosomal subunit;0.0422393101427462!GO:0005763;mitochondrial small ribosomal subunit;0.0422393101427462!GO:0006516;glycoprotein catabolic process;0.0422393101427462!GO:0031272;regulation of pseudopodium formation;0.0422393101427462!GO:0031269;pseudopodium formation;0.0422393101427462!GO:0031344;regulation of cell projection organization and biogenesis;0.0422393101427462!GO:0031268;pseudopodium organization and biogenesis;0.0422393101427462!GO:0031346;positive regulation of cell projection organization and biogenesis;0.0422393101427462!GO:0031274;positive regulation of pseudopodium formation;0.0422393101427462!GO:0043681;protein import into mitochondrion;0.0425163680618268!GO:0005977;glycogen metabolic process;0.0433519015208027!GO:0046822;regulation of nucleocytoplasmic transport;0.0437740489181628!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.0440805869166564!GO:0031406;carboxylic acid binding;0.0447163569816268!GO:0016408;C-acyltransferase activity;0.0447236243888219!GO:0016311;dephosphorylation;0.0458047117652157!GO:0015036;disulfide oxidoreductase activity;0.0464139908226426!GO:0006112;energy reserve metabolic process;0.0466493194616046!GO:0005832;chaperonin-containing T-complex;0.0473234693973185!GO:0047115;trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity;0.0473234693973185!GO:0045646;regulation of erythrocyte differentiation;0.0473353198664411!GO:0016301;kinase activity;0.0474740318909543!GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;0.0486697264003074!GO:0006629;lipid metabolic process;0.0497789206398016!GO:0043022;ribosome binding;0.049856430714274 | |||
|sample_id=10010 | |sample_id=10010 | ||
|sample_note= | |sample_note= |
Revision as of 16:35, 25 June 2012
Name: | adipose tissue, adult, pool1 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10615
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs10615
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.0672 |
10 | 10 | 0.178 |
100 | 100 | 0.0753 |
101 | 101 | 0.516 |
102 | 102 | 0.348 |
103 | 103 | 0.447 |
104 | 104 | 0.437 |
105 | 105 | 0.529 |
106 | 106 | 0.42 |
107 | 107 | 0.0862 |
108 | 108 | 0.92 |
109 | 109 | 0.0958 |
11 | 11 | 0.18 |
110 | 110 | 0.256 |
111 | 111 | 0.112 |
112 | 112 | 0.859 |
113 | 113 | 0.343 |
114 | 114 | 0.174 |
115 | 115 | 0.258 |
116 | 116 | 0.637 |
117 | 117 | 0.00751 |
118 | 118 | 0.00952 |
119 | 119 | 0.622 |
12 | 12 | 0.867 |
120 | 120 | 0.0428 |
121 | 121 | 0.433 |
122 | 122 | 0.619 |
123 | 123 | 0.00409 |
124 | 124 | 0.765 |
125 | 125 | 0.323 |
126 | 126 | 0.695 |
127 | 127 | 0.463 |
128 | 128 | 0.637 |
129 | 129 | 0.704 |
13 | 13 | 0.206 |
130 | 130 | 0.728 |
131 | 131 | 0.6 |
132 | 132 | 0.157 |
133 | 133 | 0.135 |
134 | 134 | 0.582 |
135 | 135 | 0.0802 |
136 | 136 | 0.95 |
137 | 137 | 0.48 |
138 | 138 | 0.827 |
139 | 139 | 0.939 |
14 | 14 | 0.685 |
140 | 140 | 0.0161 |
141 | 141 | 0.522 |
142 | 142 | 0.417 |
143 | 143 | 0.0327 |
144 | 144 | 0.857 |
145 | 145 | 0.435 |
146 | 146 | 0.251 |
147 | 147 | 0.274 |
148 | 148 | 0.454 |
149 | 149 | 0.262 |
15 | 15 | 0.125 |
150 | 150 | 0.902 |
151 | 151 | 0.896 |
152 | 152 | 0.186 |
153 | 153 | 0.152 |
154 | 154 | 0.465 |
155 | 155 | 0.213 |
156 | 156 | 0.896 |
157 | 157 | 0.693 |
158 | 158 | 0.304 |
159 | 159 | 0.966 |
16 | 16 | 0.684 |
160 | 160 | 0.725 |
161 | 161 | 0.391 |
162 | 162 | 0.921 |
163 | 163 | 0.667 |
164 | 164 | 0.0622 |
165 | 165 | 0.161 |
166 | 166 | 0.967 |
167 | 167 | 0.0399 |
168 | 168 | 0.604 |
169 | 169 | 0.838 |
17 | 17 | 0.737 |
18 | 18 | 0.2 |
19 | 19 | 0.127 |
2 | 2 | 0.0833 |
20 | 20 | 0.0421 |
21 | 21 | 0.997 |
22 | 22 | 0.585 |
23 | 23 | 0.113 |
24 | 24 | 0.899 |
25 | 25 | 0.494 |
26 | 26 | 0.111 |
27 | 27 | 0.672 |
28 | 28 | 0.459 |
29 | 29 | 0.0309 |
3 | 3 | 0.371 |
30 | 30 | 0.0956 |
31 | 31 | 0.868 |
32 | 32 | 0.414 |
33 | 33 | 0.355 |
34 | 34 | 0.112 |
35 | 35 | 0.402 |
36 | 36 | 0.103 |
37 | 37 | 0.381 |
38 | 38 | 0.828 |
39 | 39 | 0.009 |
4 | 4 | 0.0794 |
40 | 40 | 0.0686 |
41 | 41 | 0.766 |
42 | 42 | 0.244 |
43 | 43 | 0.568 |
44 | 44 | 0.328 |
45 | 45 | 0.153 |
46 | 46 | 0.266 |
47 | 47 | 0.123 |
48 | 48 | 0.178 |
49 | 49 | 0.0782 |
5 | 5 | 0.916 |
50 | 50 | 0.425 |
51 | 51 | 0.852 |
52 | 52 | 0.222 |
53 | 53 | 0.887 |
54 | 54 | 0.819 |
55 | 55 | 0.634 |
56 | 56 | 0.607 |
57 | 57 | 0.136 |
58 | 58 | 0.695 |
59 | 59 | 0.542 |
6 | 6 | 0.554 |
60 | 60 | 0.395 |
61 | 61 | 0.388 |
62 | 62 | 0.757 |
63 | 63 | 0.932 |
64 | 64 | 0.126 |
65 | 65 | 0.749 |
66 | 66 | 0.0177 |
67 | 67 | 0.389 |
68 | 68 | 0.282 |
69 | 69 | 0.213 |
7 | 7 | 0.712 |
70 | 70 | 0.279 |
71 | 71 | 0.0811 |
72 | 72 | 0.453 |
73 | 73 | 0.684 |
74 | 74 | 0.949 |
75 | 75 | 0.0253 |
76 | 76 | 0.0722 |
77 | 77 | 0.091 |
78 | 78 | 0.547 |
79 | 79 | 0.408 |
8 | 8 | 0.404 |
80 | 80 | 0.305 |
81 | 81 | 0.78 |
82 | 82 | 0.997 |
83 | 83 | 0.278 |
84 | 84 | 0.519 |
85 | 85 | 0.226 |
86 | 86 | 0.875 |
87 | 87 | 0.173 |
88 | 88 | 0.809 |
89 | 89 | 0.671 |
9 | 9 | 0.193 |
90 | 90 | 0.548 |
91 | 91 | 0.305 |
92 | 92 | 0.415 |
93 | 93 | 0.179 |
94 | 94 | 0.176 |
95 | 95 | 0.0133 |
96 | 96 | 0.983 |
97 | 97 | 0.308 |
98 | 98 | 0.532 |
99 | 99 | 0.435 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs10615
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000004 tissue sample
FF:0000210 human sample
FF:0010010 human adipose tissue - adult sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
UBERON: Anatomy
0000468 (multi-cellular organism)
0007023 (adult organism)
0001013 (adipose tissue)
0002384 (connective tissue)
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA